RATIONALE: Studies with genetically engineered mice showed that decreased expression of the transmembrane peptidase neprilysin (NEP) increases susceptibility to hypoxic pulmonary vascular remodeling and hypertension; in hypoxic wild-type mice, expression is decreased early in distal pulmonary arteries, where prominent vascular remodeling occurs. Therefore, in humans with smoke- and hypoxia-induced vascular remodeling, as in chronic obstructive pulmonary disease (COPD), pulmonary activity/expression of NEP may likewise be decreased. OBJECTIVES: To test whether NEP activity and expression are reduced in COPD lungs and pulmonary arterial smooth muscle cells (SMCs) exposed to cigarette smoke extract or hypoxia and begin to investigate mechanisms involved. METHODS: Control and advanced COPD lung lysates (n = 13-14) were analyzed for NEP activity and protein and mRNA expression. As a control, dipeptidyl peptidase IV activity was analyzed. Lung sections were assessed for vascular remodeling and oxidant damage. Human pulmonary arterial SMCs were exposed to cigarette smoke extract, hypoxia, or H₂O₂, and incubated with antioxidants or lysosomal/proteasomal inhibitors. MEASUREMENTS AND MAIN RESULTS: COPD lungs demonstrated areas of vascular rarification, distal muscularization, and variable intimal and prominent medial/adventitial thickening. NEP activity was reduced by 76%; NEP protein expression was decreased in alveolar walls and distal vessels; mRNA expression was also decreased. In SMCs exposed to cigarette smoke extract, hypoxia, and H₂O₂, NEP activity and expression were also reduced. Reactive oxygen species inactivated NEP activity; NEP protein degradation appeared to be substantially induced. CONCLUSIONS: Mechanisms responsible for reduced NEP activity and protein expression include oxidative reactions and protein degradation. Maintaining or increasing lung NEP may protect against pulmonary vascular remodeling in response to chronic smoke and hypoxia.
RATIONALE: Studies with genetically engineered mice showed that decreased expression of the transmembrane peptidase neprilysin (NEP) increases susceptibility to hypoxic pulmonary vascular remodeling and hypertension; in hypoxic wild-type mice, expression is decreased early in distal pulmonary arteries, where prominent vascular remodeling occurs. Therefore, in humans with smoke- and hypoxia-induced vascular remodeling, as in chronic obstructive pulmonary disease (COPD), pulmonary activity/expression of NEP may likewise be decreased. OBJECTIVES: To test whether NEP activity and expression are reduced in COPD lungs and pulmonary arterial smooth muscle cells (SMCs) exposed to cigarette smoke extract or hypoxia and begin to investigate mechanisms involved. METHODS: Control and advanced COPD lung lysates (n = 13-14) were analyzed for NEP activity and protein and mRNA expression. As a control, dipeptidyl peptidase IV activity was analyzed. Lung sections were assessed for vascular remodeling and oxidant damage. Human pulmonary arterial SMCs were exposed to cigarette smoke extract, hypoxia, or H₂O₂, and incubated with antioxidants or lysosomal/proteasomal inhibitors. MEASUREMENTS AND MAIN RESULTS: COPD lungs demonstrated areas of vascular rarification, distal muscularization, and variable intimal and prominent medial/adventitial thickening. NEP activity was reduced by 76%; NEP protein expression was decreased in alveolar walls and distal vessels; mRNA expression was also decreased. In SMCs exposed to cigarette smoke extract, hypoxia, and H₂O₂, NEP activity and expression were also reduced. Reactive oxygen species inactivated NEP activity; NEP protein degradation appeared to be substantially induced. CONCLUSIONS: Mechanisms responsible for reduced NEP activity and protein expression include oxidative reactions and protein degradation. Maintaining or increasing lung NEP may protect against pulmonary vascular remodeling in response to chronic smoke and hypoxia.
Authors: S Santos; V I Peinado; J Ramírez; T Melgosa; J Roca; R Rodriguez-Roisin; J A Barberà Journal: Eur Respir J Date: 2002-04 Impact factor: 16.671
Authors: Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller Journal: Am J Pathol Date: 2009-03 Impact factor: 4.307
Authors: Georgina M Aldridge; David M Podrebarac; William T Greenough; Ivan Jeanne Weiler Journal: J Neurosci Methods Date: 2008-05-15 Impact factor: 2.390
Authors: A J Cohen; P A Bunn; W Franklin; C Magill-Solc; C Hartmann; B Helfrich; L Gilman; J Folkvord; K Helm; Y E Miller Journal: Cancer Res Date: 1996-02-15 Impact factor: 12.701
Authors: Simon S Wong; Nina N Sun; Cynthia D Fastje; Mark L Witten; R Clark Lantz; Bao Lu; Duane L Sherrill; Craig J Gerard; Jefferey L Burgess Journal: Res Rep Health Eff Inst Date: 2011-06
Authors: Marilee J Wick; Erica J Buesing; Carol A Wehling; Zoe L Loomis; Carlyne D Cool; Martin R Zamora; York E Miller; Sean P Colgan; Louis B Hersh; Norbert F Voelkel; Edward C Dempsey Journal: Am J Respir Crit Care Med Date: 2010-09-02 Impact factor: 21.405
Authors: Jessica L Sitnik; Carmen Francis; Korneel Hens; Roger Huybrechts; Mariana F Wolfner; Patrick Callaerts Journal: Genetics Date: 2014-01-06 Impact factor: 4.562
Authors: Melissa A Lyle; Seethalakshmi R Iyer; Margaret M Redfield; Yogesh N V Reddy; G Michael Felker; Thomas P Cappola; Adrian F Hernandez; Christopher G Scott; John C Burnett; Naveen L Pereira Journal: JACC Heart Fail Date: 2019-08-07 Impact factor: 12.035
Authors: Vijaya Karoor; Masahiko Oka; Sandra J Walchak; Louis B Hersh; York E Miller; Edward C Dempsey Journal: Hypertension Date: 2013-02-04 Impact factor: 10.190
Authors: Marilee J Wick; Zoe L Loomis; Julie W Harral; Mysan Le; Carol A Wehling; York E Miller; Edward C Dempsey Journal: Transgenic Res Date: 2016-07-01 Impact factor: 2.788
Authors: Katharina Leithner; Christoph Wohlkoenig; Elvira Stacher; Jörg Lindenmann; Nicole A Hofmann; Birgit Gallé; Christian Guelly; Franz Quehenberger; Philipp Stiegler; Freyja-Maria Smolle-Jüttner; Sjaak Philipsen; Helmut H Popper; Andelko Hrzenjak; Andrea Olschewski; Horst Olschewski Journal: BMC Cancer Date: 2014-01-25 Impact factor: 4.430